Criteria for the diagnosis of corticobasal degeneration
By M. Armstrong, I. Litvan, A. Lang, T. Bak, Kailash Bhatia, B. Borroni, A. Boxer, Dennis W. Dickson, Murray C. Grossman, Mark Hallett and 10 more. Neurology, 2013
1,623 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Neurology
View Paper: https://www.semanticscholar.org/paper/ef96fc2eeac08fbd59e2721c861775505768fccf
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Neurology
- Henrik Zetterberg
- Kaj Blennow
- Oskar Hansson
- Brittany N. Dugger
- Dennis W. Dickson
- Yaakov Stern
- Bruno Dubois
- William E. Klunk
Citations in the corpus
- A comprehensive review of amyotrophic lateral sclerosis (2015, background): “Neurodegenerative diseases Corticobasal degeneration Focal dystonia and myoclonia of the limbs, various clinical presentation and progression[99] Current clinical diagnostic criteria under review[11]”
- Clinical diagnosis of Alzheimer’s disease: recommendations of the International Working Group (2021, background): “Other phenotypes, including the behavioural/dysexecutive variant 70,71 , the cortico-basal variant 72,73 , and the other variants of primary progressive aphasia 69,74 (Supplementary Figure 1), are less commonly related to AD pathology (uncommon AD phenotypes).”
- Pathology of Neurodegenerative Diseases. (2017, background): “, atypical AD), the antemortem diagnostic accuracy of CBD is poor, and recent clinical criteria reflect this fact (Armstrong et al. 2013).”
- Validating novel tau PET tracer [F-18]-AV-1451 (T807) on postmortem brain tissue (2015, background): “The presence of brain aggregates of abnormally hyperphosphorylated tau in the form of filaments and neurofibrillary tangles (NFT) is a defining pathological hallmark of AD and other tauopathies, such as some types of frontotemporal lobe degeneration (FTLD)-tau including Pick disease (PiD),(4) progre”
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia (2020, background): “2017) and corticobasal syndrome (CBS) (fulfilling the criteria defined by Armstrong et al.(Armstrong et al. 2013)).”
- Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. (2018, background): “…supranuclear palsy syndrome Three of (i) axial or symmetric limb rigidity or akinesia, (ii) postural instability or falls, (iii) urinary incontinence, (iv) behavioral changes, (v) supranuclear gaze palsy or decreased velocity of vertical saccades Source: Litvan et al. 1996a; Armstrong et al. 2013.”